Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20192192 | 0.91 | MEN1 (0.33) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL18637296 | 0.84 | ERN1 (0.35) | ERN1 | |
| SCHEMBL18637030 | 0.79 | ERN1 (0.38) | ERN1MEN1USP2POLBPPARG | |
| SCHEMBL15483660 | 0.75 | MEN1 (0.45) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL20192126 | 0.73 | MEN1 (0.38) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL20192151 | 0.72 | MEN1 (0.45) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL15704723 | 0.70 | MEN1 (0.61) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL18637297 | 0.63 | ERN1 (0.38) | ERN1MEN1USP2KMT2A | |
| SCHEMBL19635158 | 0.61 | MEN1 (0.42) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL19494774 | 0.60 | USP2 (0.53) | MEN1USP2POLBPPARGBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170073321-A1 | ENZYME-SPECIFIC FLUORESCENT COMPOUND CAPABLE OF BEING RETAINED IN CELLS | THE UNIVERSITY OF TOKYO (JP) | 2017-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170073321-A1 | ENZYME-SPECIFIC FLUORESCENT COMPOUND CAPABLE OF BEING RETAINED IN CELLS | GLB1, GLA, GUSB | ERN1 1216/4885MEN1 2639/4885USP2 3117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.